Skip to main content
OpenTrials

Clinical trial condition

Telangiectasia, Hereditary Hemorrhagic

Explore clinical trials studying Telangiectasia, Hereditary Hemorrhagic. Study availability and eligibility vary by location and protocol.

90 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Telangiectasia, Hereditary Hemorrhagic trial results

Completed

Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitudinal Assessment Study

NCT07018401

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
Locations
  • University of California-San Diego San Diego, California, United States
  • University of California-San Francisco San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia

NCT01158807

Conditions
Arteriovenous Malformations, Brain Diseases, Cardiovascular Abnormalities, +19 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • David Geffen School of Medicine at University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 19 locations
View Trial Details

Related conditions